FDA.reportPublic FDA data

denosumab-kyqq 120 MG per 1.7 ML Injection

RxCUI
2725939
RxNorm name
denosumab-kyqq 120 MG per 1.7 ML Injection
Display name
denosumab-kyqq 120 MG per 1.7 ML Injection
Full name
denosumab-kyqq 120 MG per 1.7 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761436Bosayadenosumab-kyqq351(k) InterchangeableRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AUKELSODENOSUMAB-KYQQBiocon Biologics Inc.547cb095-f7f5-f933-75ce-5e6abf2ad5bc2026-03-27Warnings, Adverse reactionsExact identifier
rxcui: 2725939

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
547cb095-f7f5-f933-75ce-5e6abf2ad5bcdenosumab-kyqq 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab-kyqq 70 MG/ML Injection [SCD] · denosumab-kyqq 120 MG per 1.7 ML Injection [SY]32These highlights do not include all the information needed to use AUKELSO safely and effectively. See full prescribing information for AUKELSO. AUKELSO TM (denosumab-kyqq) injection, for subcutaneous use Initial U.S. Approval: 2025 AUKELSO TM (denosumab-kyqq) is biosimilar* to XGEVA ® (denosumab).20250916